These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10150367)

  • 41. [Progress in medical treatment of heart failure].
    López Mora E
    Arch Cardiol Mex; 2001; 71 Suppl 1():S95-101. PubMed ID: 11565355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What is the optimal medical management of ischemic heart failure?
    Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M
    Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tailored therapy to hemodynamic goals for advanced heart failure.
    Stevenson LW
    Eur J Heart Fail; 1999 Aug; 1(3):251-7. PubMed ID: 10935671
    [No Abstract]   [Full Text] [Related]  

  • 44. [Revised insights and therapeutic goals in the treatment of chronic heart failure].
    van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1507-11. PubMed ID: 10443272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacotherapy of chronic heart failure].
    Hoppe UC
    Z Arztl Fortbild Qualitatssich; 2003 Apr; 97(2):113-9. PubMed ID: 12806816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The treatment of heart failure in the elderly patient with comorbidities.
    Briscoe TA; Earle SR; Lob MK; Somerville LL
    Director; 2004; 12(1):36-41. PubMed ID: 19178116
    [No Abstract]   [Full Text] [Related]  

  • 47. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
    O'Connor CM; Arumugham P
    Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flosequinan for heart failure.
    Med Lett Drugs Ther; 1993 Mar; 35(892):23-4. PubMed ID: 8441362
    [No Abstract]   [Full Text] [Related]  

  • 50. [Advance in the treatment of heart failure in children].
    Ma PR; Huang L; Jiang HL
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):744-6. PubMed ID: 17229375
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of heart failure: update 1994.
    Krueger SK; Mahapatra S; Gangahar DM; Wilson CS; Turk KT; Vermaas PL
    Nebr Med J; 1994 Aug; 79(8):292-7. PubMed ID: 7990994
    [No Abstract]   [Full Text] [Related]  

  • 52. Surviving heart failure: Robert L. Frye lecture.
    Parmley WW
    Mayo Clin Proc; 2000 Jan; 75(1):111-8. PubMed ID: 10630765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prescribing and emergency admissions for heart failure in greater Glasgow.
    Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
    J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The 95% confidence interval and the p-value].
    Steurer J
    Praxis (Bern 1994); 1998 Jan; 87(4):114-5. PubMed ID: 9522641
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapy of congestive cardiac insufficiency. A challenge].
    Luís AS; Ceia F
    Rev Port Cardiol; 1991 Sep; 10(9):647-52; author reply 570-1. PubMed ID: 1747255
    [No Abstract]   [Full Text] [Related]  

  • 56. The growing burden of heart failure.
    Rapeport N
    S Afr Med J; 2002 Feb; 92(2):126-7. PubMed ID: 11894644
    [No Abstract]   [Full Text] [Related]  

  • 57. Heart failure: drug therapy in the nineties and beyond.
    Conti CR
    Clin Cardiol; 1993 Jun; 16(6):459-60. PubMed ID: 8358878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heart failure--perspective on some controversial issues for the clinician. 20th Biennial Congress of the Cardiac Society, October 1996.
    S Afr Med J; 1997 Feb; 87 Suppl 1():C58. PubMed ID: 9186454
    [No Abstract]   [Full Text] [Related]  

  • 59. The economics of therapeutic advances: the paradigm of sympathetic suppression in chronic heart failure.
    Gavras I; Manolis AJ; Gavras H
    Arch Intern Med; 1999 Dec 13-27; 159(22):2634-6. PubMed ID: 10597753
    [No Abstract]   [Full Text] [Related]  

  • 60. The investigation and management of patients with heart failure.
    Saunderson EM
    Br J Gen Pract; 1996 Sep; 46(410):551-2. PubMed ID: 8917880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.